Want to create an interactive transcript for this episode?
Podcast: Surfing the MASH Tsunami
Episode: S2-E26.3 - How much will real-life NASH treatment decisions depend on the specialty of the prescriber?
Description: azen Noureddin returns to discuss the roles different drugs and drug classes will play in NASH therapy after current Phase 2b and Phase 3 candidates have been approved. This conversation considers how the idea that front-line treaters will be PCPs might affect treatment patterns. This conversation starts with Roger Green pointing out that most real-world patient treatment decisions will be made by front-line, primary care physicians. Stephen Harrison proposes one more application for the "KISS" rule and talks about the role of EHRs in driving long-term guideline development and adherence. Mazen Noureddin considers how order of...